What You Should Know:
- Epic was named the top Overall Software Suite for the eleventh consecutive year in the Best in KLAS 2021 Software & Services report, released today, which reports on the top vendors for 2020. Epic was also named the top Overall Physician Practice Vendor. Galen Healthcare Solutions was named the top Overall IT Services Firm. The Chartis Group earned the award of top Overall Healthcare Management Consulting Firm, edging out last year’s winner,
Read More
Pharmacy | Medication Adherence Technology Services and Solutions | News, Analysis, Insights - HIT Consultant
Capital Rx Secures $50 Million to Redefine Prescription Pricing
What You Should Know:
- Capital Rx, the fastest-growing pharmacy benefit manager in the U.S., announced today that it has raised $50 million in Series B financing.
- Following the recent launch of JUDITM, the industry’s first Enterprise Pharmacy Platform, Capital Rx will continue to expand the platform’s capabilities, including leveraging AI to improve clinical care.
Capital Rx, a New York City-based pharmacy benefit manager in the U.S., announced it has raised $50 million in Series B
Read More
Humana Taps DispatchHealth to Power Hospital-Level Care in the Home
What You Should Know:
- Humana Inc. and DispatchHealth, a provider of in-home medical care, today announced an agreement to provide Humana members with access to an advanced level of care in the home – to help enhance patients’ experience and health outcomes. The Dispatch-Humana agreement is believed to be the country’s first program to provide hospital-level care involving a national payer.
- The agreement will provide members living with multiple chronic conditions – such as cellulitis,
Read More
Tech-Enabled PBO RxBenefits Reaches $1.1B Valuation After Recapitalization
What You Should Know:
- Private equity firm Advent International announced that
it has completed a recapitalization of RxBenefits, the employee benefits
industry’s first and only technology-enabled pharmacy benefits optimizer (PBO).
- The transaction values RxBenefits at approximately $1.1
billion.
Advent International (“Advent”), one of the largest and most experienced global private equity investors, today announced that it has completed a recapitalization of RxBenefits, the
Read More
Transitioning from Traditional to E-Fax: How Healthcare Communications are Transforming Post-COVID
The majority of industries have decreased or eliminated their use of the traditional fax machine over the past decade, including aviation, retail, and even finance. While the healthcare industry is at the forefront of disease research and treatment, however, it is still heavily reliant on this aging technology.
Traditional fax has become ubiquitous in healthcare. It worked for health systems for many years, but the overwhelming volume of patient data and paper documents the healthcare
Read More
NeuroFlow Secures $20M for Tech-Enabled Behavioral Health Integration Platform
What You Should Know:
- NeuroFlow raises $20M to expand its technology-enabled behavioral
health integration platform, led by Magellan Health.
- NeuroFlow’s suite of HIPAA-compliant, cloud-based tools
simplify remote patient monitoring, enable risk stratification, and facilitate
collaborative care. With NeuroFlow, health care organizations can finally
bridge the gap between mental and physical health in order to improve outcomes
and reduce the cost of care.
NeuroFlow, a
Read More
Shields Health Solutions, ExceleraRx Announce Specialty Pharmacy Merger – M&A
What You Should Know:
- Shields Health Solutions and Excelera announce a major
specialty pharmacy merger that will form a combined company that consults with
700+ hospitals in 43 states, including Mass General Brigham, Yale New Haven,
Intermountain Healthcare and Henry Ford.
- The network of hospitals is designed to improve patient
care through an infrastructure that helps with things like acquiring prior
authorization for specialty drugs and staying adherent to them. It can also
lower
Read More
Why A Patient-First Strategy for Specialty Rx Pharmacists Is Critical to Optimize Outcomes
One of the biggest challenges for biopharmaceutical companies of rare and orphan disease patient populations is optimizing disease management in a way that enhances the patient journey and improves outcomes. As these companies seek innovative solution partners, a patient-first approach that offers specialty Rx pharmacist expertise is critical for securing insurance coverage, coordinating care, ensuring compliance, and, ultimately, minimizing the daily impact of rare and orphan
Read More
2020’s Top 20 Digital Health M&A Deals Totaled $50B
Teladoc Health and Livongo Merge
The combination of Teladoc Health and Livongo creates a
global leader in consumer-centered virtual care. The combined company is
positioned to execute quantified opportunities to drive revenue synergies of
$100 million by the end of the second year following the close, reaching $500
million on a run-rate basis by 2025.
Price: $18.5B in value based on each share of Livongo
will be exchanged for 0.5920x shares of Teladoc Health plus cash consideration
of
Read More
Patient-First Model: High Tech Meets High Touch for Individuals with Rare Disorders
Industry experts state that orphan drugs will be a major trend to watch in the years ahead, accounting for almost 40% of the Food and Drug Administration approvals this year. This market has become more competitive in the past few years, increasing the potential for reduced costs and broader patient accessibility. Currently, these products are often expensive because they target specific conditions and cost on average $147,000 or more per year, making commercialization
Read More
